The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2018
Filed:
Aug. 13, 2013
Applicant:
N.v. Nutricia, Zoetermeer, NL;
Inventors:
Martine Groenendijk, Utrecht, NL;
Robert Johan Joseph Hageman, Utrecht, NL;
Mattheus Cornelis De Wilde, Utrecht, NL;
Assignee:
N.V. Nutricia, Zoetermeer, NL;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7072 (2006.01); A61K 31/202 (2006.01); A61K 31/4415 (2006.01); A61K 31/14 (2006.01); A61K 31/66 (2006.01); A61K 33/30 (2006.01); A61K 33/06 (2006.01); A61K 31/714 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); A61K 31/685 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7072 (2013.01); A61K 31/14 (2013.01); A61K 31/202 (2013.01); A61K 31/4415 (2013.01); A61K 31/519 (2013.01); A61K 31/66 (2013.01); A61K 31/685 (2013.01); A61K 31/714 (2013.01); A61K 33/06 (2013.01); A61K 33/30 (2013.01); A61K 45/06 (2013.01);
Abstract
This invention pertains to the use of an uridine source, preferably uridine monophosphate, for increasing, controlling and/or maintaining fasting plasma uridine concentrations in a range of 4 to 8 μM in a subject in need thereof, comprising administering to said subject a composition comprising 300-900 mg of said uridine source daily for a period of at least 4 weeks. In particular, the use of an uridine source is intended forelderly and/or subjects suffering from neurological disorders such as Alzheimer's Disease and dementia syndromes.